Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.42% |
| Dec 31, 2025 | 49.52% |
| Sep 30, 2025 | 47.80% |
| Jun 30, 2025 | 7.40% |
| Mar 31, 2025 | 76.50% |
| Dec 31, 2024 | 77.09% |
| Sep 30, 2024 | 142.53% |
| Jun 30, 2024 | 158.34% |
| Mar 31, 2024 | 58.27% |
| Dec 31, 2023 | 54.53% |
| Sep 30, 2023 | 92.51% |
| Jun 30, 2023 | 73.27% |
| Mar 31, 2023 | 38.22% |
| Dec 31, 2022 | 32.48% |
| Sep 30, 2022 | -14.34% |
| Jun 30, 2022 | -30.38% |
| Mar 31, 2022 | 34.00% |
| Dec 31, 2021 | 36.33% |
| Sep 30, 2021 | 39.95% |
| Jun 30, 2021 | -38.33% |